2021全球1000強藥企名單發布 2021世界千強藥企名單一覽全球千強藥企有哪些

本文章由注冊用戶排了個榜上傳提供 2024-03-29 評論 0

國際投行Torreya公司發布了2021年《全球1000強藥企報告》，該報告按估值對全球前1000家藥企進行了排名，提供了2021年全球制藥行業的最新發展概況。在這1000家企業中，中國有249家醫藥企業上榜，在全球Top100藥企中，有20家醫藥企業上榜；在上榜的中國企業中，前五名為恒瑞醫藥、石藥集團、齊魯制藥、揚子江藥業、片仔癀。下面跟隨小編一起來看看榜單詳細內容吧。

全球千強藥企榜單解讀

美食

該(gai)報告顯示，全球制(zhi)(zhi)藥行業(ye)排名前五的國家是美國、中(zhong)國、瑞士、英(ying)國和德國，中(zhong)國已經進入(ru)全球制(zhi)(zhi)藥第二梯隊。

相比2020年(nian)千強中(zhong)國(guo)上榜208家，2021年(nian)中(zhong)國(guo)醫(yi)(yi)藥(yao)(yao)(yao)企(qi)(qi)業數量同比增長19.71%。入(ru)圍(wei)的中(zhong)國(guo)企(qi)(qi)業中(zhong)，前五名(ming)為恒瑞(rui)醫(yi)(yi)藥(yao)(yao)(yao)、石藥(yao)(yao)(yao)集團(tuan)、齊魯制藥(yao)(yao)(yao)、揚子江藥(yao)(yao)(yao)業、片(pian)仔癀。其(qi)中(zhong)，恒瑞(rui)醫(yi)(yi)藥(yao)(yao)(yao)已連續兩年(nian)在中(zhong)國(guo)入(ru)榜藥(yao)(yao)(yao)企(qi)(qi)中(zhong)排名(ming)第(di)一。

此外，入圍(wei)前100強的中國藥(yao)(yao)(yao)企(qi)共20家。分別為：恒瑞醫(yi)藥(yao)(yao)(yao)排(pai)名(ming)(ming)(ming)(ming)(ming)第(di)(di)(di)(di)(di)(di)(di)24名(ming)(ming)(ming)(ming)(ming)，石藥(yao)(yao)(yao)集(ji)團排(pai)名(ming)(ming)(ming)(ming)(ming)第(di)(di)(di)(di)(di)(di)(di)25名(ming)(ming)(ming)(ming)(ming)，齊魯(lu)制藥(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)(di)26名(ming)(ming)(ming)(ming)(ming)，揚(yang)子江藥(yao)(yao)(yao)業(ye)第(di)(di)(di)(di)(di)(di)(di)28名(ming)(ming)(ming)(ming)(ming)，片仔癀(huang)第(di)(di)(di)(di)(di)(di)(di)33名(ming)(ming)(ming)(ming)(ming)，智飛生(sheng)(sheng)物第(di)(di)(di)(di)(di)(di)(di)36名(ming)(ming)(ming)(ming)(ming)，百(bai)濟(ji)神州第(di)(di)(di)(di)(di)(di)(di)38名(ming)(ming)(ming)(ming)(ming)，復星醫(yi)藥(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)(di)53名(ming)(ming)(ming)(ming)(ming)，愛美(mei)客(ke)第(di)(di)(di)(di)(di)(di)(di)54名(ming)(ming)(ming)(ming)(ming)，長春生(sheng)(sheng)物第(di)(di)(di)(di)(di)(di)(di)57名(ming)(ming)(ming)(ming)(ming)，科(ke)倫藥(yao)(yao)(yao)業(ye)第(di)(di)(di)(di)(di)(di)(di)59名(ming)(ming)(ming)(ming)(ming)，濟(ji)民可信(xin)第(di)(di)(di)(di)(di)(di)(di)60名(ming)(ming)(ming)(ming)(ming)，中國生(sheng)(sheng)物制藥(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)(di)67名(ming)(ming)(ming)(ming)(ming)，云(yun)南白藥(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)(di)71名(ming)(ming)(ming)(ming)(ming)，沃森生(sheng)(sheng)物第(di)(di)(di)(di)(di)(di)(di)74名(ming)(ming)(ming)(ming)(ming)，信(xin)達(da)生(sheng)(sheng)物第(di)(di)(di)(di)(di)(di)(di)77名(ming)(ming)(ming)(ming)(ming)，康泰生(sheng)(sheng)物第(di)(di)(di)(di)(di)(di)(di)78，豪(hao)森藥(yao)(yao)(yao)業(ye)第(di)(di)(di)(di)(di)(di)(di)82名(ming)(ming)(ming)(ming)(ming)，上(shang)海醫(yi)藥(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)(di)88名(ming)(ming)(ming)(ming)(ming)，華東醫(yi)藥(yao)(yao)(yao)第(di)(di)(di)(di)(di)(di)(di)92名(ming)(ming)(ming)(ming)(ming)。

2021全球1000強藥企名單TOP100

排名	企業名稱	公司估值	年收入
1	輝瑞公司Pfizer	$289bn	$69bn
2	艾伯維AbbVie	$276bn	$54bn
3	羅氏制藥Roche Pharma Segment	$264bn	$50bn
4	諾和諾德公司Novo Nordisk	$254bn	$21bn
5	禮來公司Eli Lilly	$252bn	$28bn
6	楊森Janssen（J&J Rx Seg）	$241bn	$46bn
7	默克公司Merck	$224bn	$53bn
8	阿斯利康AstraZeneca	$208bn	$30bn
9	諾華公司Novartis	$192bn	$52bn
10	葛蘭素史克公司GSK Pharma Segment	$173bn	$33bn
11	百時美施貴寶公司Bristol-Myers Squibb	$161bn	$45bn
12	賽諾菲Sanofi	$142bn	$45bn
13	安進公司Amgen	$139bn	$26bn
14	勃林格殷格翰Boehringer Ingelheim	$121bn	$23bn
15	拜耳Bayer Pharma Segment	$112bn	$21bn
16	CSL	$110bn	$10bn
17	碩騰Zoetis	$106bn	$7.6bn
18	吉利德科學公司Gilead	$103bn	$27bn
19	莫德納公司Moderna	$88bn	$11.8bn
20	武田制藥Takeda	$76.7bn	$30bn
21	Chugai	$58.2bn	$8bn
22	再生元制藥公司Regeneron	$55.2bn	$13bn
23	BioNTech	$51.5bn	$9.2bn
24	恒瑞醫藥Hengrui Medicine	$48.9bn	$4.4bn
25	石藥集團CSPC Pharma	$47bn	$6.5bn
26	齊魯制藥Qilu Pharma	$44.3bn	$4.3bn
27	福泰制藥Vertex Pharma	$42.9bn	$7.1bn
28	揚子江藥業Yangtze River Pharma	$42.9bn	$16bn
29	默克集團Merck KGaA Rx Seg	$42.9bn	$8.1bn
30	第一三共株式會社Daiichi Sankyo	$41.5bn	$9.1bn
31	暉致醫藥有限公司Viatris	$40.5bn	$16bn
32	渤健Biogen	$40.2bn	$11bn
33	片仔癀公司Pientzehuang Pharma	$38.7bn	$1.2bn
34	以色列梯瓦制藥集團Teva	$33.2bn	$16bn
35	美國博士康BauschHealth	$32.9bn	$8.5bn
36	智飛生物ZhifelBio	$32.6bn	$4bn
37	Seagen	$32.5bn	$1.7bn
38	百濟神州BeiGene	$31bn	$1.1bn
39	安斯泰來制藥Astellas	$29.7bn	$12bn
40	RoyaltyPharma	$29bn	$2.3bn
41	施維雅Servier	$29bn	$5.5bn
42	Genmab	$27.8bn	$1.2bn
43	Horizon Therapeutics	$26.7bn	$3bn
44	印度太陽藥業Sun Pharma	$24.8bn	$4.9bn
45	美納里尼Menarini	$24.7bn	$4.7bn
46	比利時優時比制藥公司UCB	$24.5bn	$6.5bn
47	基立福公司Grifols	$226bn	$6.2bn
48	韓國賽爾群公司Celltrion	$22.1bn	$1.7bn
49	禮來動保Elanco	$21.7bn	$46bn
50	阿爾尼拉姆制藥Alnylam	$20.8bn	$749Mio
51	大冢制藥Otsuka	$20bn	$13bn
52	衛材藥業Eisai	$19.7bn	$6.2bn
53	復星醫藥Fosun Pharma	$19.6bn	$5.5bn
54	愛美客Imeik Technology	$18.5bn	$197Mio
55	日本鹽野義制藥株式會社Shionogi	$18.1bn	$2.6bn
56	荷蘭歐加農Organon	$18.1bn	$7.9bn
57	長春生物Changchun Tech	$17.9bn	$1.6bn
58	高德美實驗室Galderma	$16.3bn	$3.1bn
59	科倫藥業Kelun Group	$16.1bn	$6bn
60	濟民可信Jemincare	$16.1bn	$6bn
61	Chies	$15.8bn	$2.6bn
62	韓國SK生物科學SK Bioscience	$15.6bn	$374Mio
63	Bio Marin	$154bn	$1.8bn
64	雅培Abbott EPD	$154bn	54.3bn
65	協和麒麟Kyowa Kirin	$14.8bn	$3bn
66	奧克特琺瑪Octapharma	$14.8bn	$2.8bn
67	中國生物制藥Sino Biopharma	$14.7bn	$3.9bn
68	爵士制藥Jazz Pharma	$14.3bn	$2.6bn
69	意大利利康化工及制藥有限公司Recordati	$14.3bn	$1.8bn
70	法國第三制藥集團Pierre Fabre	$14.2bn	$2.7bn
71	云南白藥Yunnan Baiyao	$14bn	$5.8bn
72	argenx	$13.7bn	$510Mio
73	Incyte	$12.8bn	$2.9bn
74	沃森生物Walvax	$12.7bn	$543Mio
75	史達德STADA	$12.7bn	$3.2bn
76	輝凌醫藥Ferring	$12bn	$2.3bn
77	信達生物Innovent Biologics	$11.5bn	$744Mio
78	康泰生物Kangtai Bio	$11.4bn	$499Mio
79	印度瑞迪博士Dr. Reddy's	$10.7bn	$2.7bn
80	R-Pharm	$10.6bn	$2bn
81	Mundipharma	$10.6bn	$2bn
82	翰森制藥Hansoh Pharma	$10.4bn	$1.4bn
83	諾瓦瓦克斯醫藥Novavax	$10.2bn	$1.2bn
84	NC Pharma/EMS	$10bn	$1.9bn
85	費森尤斯卡比醫藥Fresenius Kabi Segment	$10bn	$3.7bn
86	Acceleron	$10bn	$113Mio
87	Ono	$10bn	$3bn
88	上海醫藥Shanghai Pharma-Rx Seg	$9.7bn	$3.6bn
89	Biohaven	$9.7bn	$190Mio
90	西普拉Cipla	$9.6bn	$2.8bn
91	Intellia Therapeutics	$9.5bn	$27Mio
92	華東醫藥Huadong Medicine	$9.5bn	$5.3bn
93	蘇庇醫藥Sobi	$9.4bn	$1.7bn
94	Grupo Insud	$9.3bn	$1.8bn
95	Intas Pharma	$9.2bn	$2.2bn
96	Tianjin Pharma	$8.9bn	$3.3bn
97	Vifor Pharma	$8.9bn	$1.9bn
98	博萊科Bracco	$8.6bn	$1.6bn
99	利奧制藥LEO Pharma	$8.6bn	$1.6bn
100	益普生Ipsen	$8.6bn	$3.3bn